Bacteremia with CDC group IV c-2 in an immunocompetent infant

Clinical Infectious Diseases

Volumn 29, Issue 6, 1999, Pages 1572-

  Noyola, Daniel E ^a,b   Edwards, Morven S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CEFOTETAN; CEFTRIAXONE; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; TIMENTIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CELL COUNT; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOCOMPETENCE; INFANT; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

BACTEREMIA; CEFOTAXIME; CEPHALOSPORINS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPETENCE; INFANT;

EID: 0033390352     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313538     Document Type: Article

References (5)

1. 1. Thayu M, Baltimore RS, Sleight BJ, Reyes-Mugica M, Hotez PJ. CDC group IV c-2 bacteremia in a child with recurrent acute monoblastic leukemia. Pediatr Infect Dis J 1999;18:397-8.
2. 2. Pickett MJ, Greenwood JR. Identification of oxidase-positive, glucose-negative, motile species of nonfermentative bacilli. J Clin Microbiol 1986;23: 920-3.
3. 3. Weyant RS, Moss CW, Weaver RE, et al. Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria. 2d ed. Baltimore: Williams & Wilkins, 1996.
4. 4. Salar A, Carratala J, Zurita A, Gonzalez-Barca E, Graneca A. Bacteremia caused by CDC group IV c-2 in a patient with acute leukemia. Haematologica 1998;83:670-2.
5. 5. Hansen W, Glupczynski Y. Group IV c-2-associated peritonitis. Clin Microbiol Newsl 1985;7:43-4.